Cross-sectional Study to Investigate the Effects of Chronic Obstructive Pulmonary Disease on Daily Life Activities (COPD LIFE)

July 20, 2011 updated by: AstraZeneca

Cross-sectional Observational Study to Investigate the Effects of Chronic Obstructive Pulmonary Disease on Daily Life Activities

The purpose of this study is to investigate the effects of Chronic Obstructive Pulmonary Disease (COPD) on daily life activities in patients with COPD and also to determine the socio-demographic profile, daily life style and needs of the patients with COPD.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

497

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
      • Adana, Turkey
        • Research Site
      • Ankara, Turkey
        • Research Site
      • Antalya, Turkey
        • Research Site
      • Aydin, Turkey
        • Research Site
      • Bartin, Turkey
        • Research Site
      • Bolu, Turkey
        • Research Site
      • Burdur, Turkey
        • Research Site
      • Bursa, Turkey
        • Research Site
      • Gaziantep, Turkey
        • Research Site
      • Gebze, Turkey
        • Research Site
      • Giresun, Turkey
        • Research Site
      • Isparta, Turkey
        • Research Site
      • Istanbul, Turkey
        • Research Site
      • Izmir, Turkey
        • Research Site
      • Karabuk, Turkey
        • Research Site
      • Kayseri, Turkey
        • Research Site
      • Konya, Turkey
        • Research Site
      • Manisa, Turkey
        • Research Site
      • Mersin, Turkey
        • Research Site
      • Yozgat, Turkey
        • Research Site

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

45 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Outpatients from health institutions where the patients with COPD are treated

Description

Inclusion Criteria:

  • Diagnosis of COPD
  • Outpatient treatment for any reason
  • Current or ex-smoker

Exclusion Criteria:

  • An exacerbation of COPD that still lasts or that was experienced within last 3 months
  • History of asthma and/or allergic rhinitis
  • The presence of another important respiratory disease

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Patients with COPD

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Effect of COPD on daily activities
Time Frame: 1 year
The distribution of the patients according to their answers, as Yes / No / Unknown, given to the questions of patient questionnaire about the effect of COPD on daily life and which daily activities are limited will be calculated as percentage.
1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patients' socio-demographic profiles, daily life conditions and needs and expectations from therapy
Time Frame: Baseline
The answers the patients give to the questions about socio-demographic profiles, daily life conditions and needs and their expectations from the therapy will be summarized as percentages: Age and gender, educational background, place of residence, marital status and life conditions, concomitant diseases, smoking status, the diagnosis of COPD and its clinical characteristics basic knowledge of the patient about COPD daily life of the patient, expectations from the therapy.
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

AstraZeneca

Investigators

  • Study Director: Zeynep Goztas, AstraZeneca Turkey
  • Principal Investigator: Mehmet Polatli, Adnan Menderes University Faculty of Medicine

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2011

Primary Completion (Actual)

June 1, 2011

Study Completion (Actual)

June 1, 2011

Study Registration Dates

First Submitted

March 21, 2011

First Submitted That Met QC Criteria

March 29, 2011

First Posted (Estimate)

March 30, 2011

Study Record Updates

Last Update Posted (Estimate)

July 21, 2011

Last Update Submitted That Met QC Criteria

July 20, 2011

Last Verified

July 1, 2011

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • NIS-RTR-XXX-2011/1

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe